Terms: = Thyroid cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Diagnosis
16 results:
1. Quaterization Derivatization with Bis(Pyridine) Iodine Tetrafluoroboride: High-Sensitivity Mass Spectrometric Analysis of Unsaturated Fatty Acids in Human thyroid Tissues.
Cheng J; Li Y; Wang Y; Zhang J; Sun T; Zhang L; Guo Y
Anal Chem; 2022 Aug; 94(32):11185-11191. PubMed ID: 35916214
[TBL] [Abstract] [Full Text] [Related]
2. Recognition of Key Genes in Human Anaplastic thyroid cancer via the Weighing Gene Coexpression Network.
Gong Y; Xu F; Deng L; Peng L
Biomed Res Int; 2022; 2022():2244228. PubMed ID: 35782055
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing thyroid cancer.
Li N; Zhang J; Meng X; Yao W
J Healthc Eng; 2022; 2022():7851436. PubMed ID: 35392142
[TBL] [Abstract] [Full Text] [Related]
4. Anti-cancer impact of Hypericin in B-CPAP cells: Extrinsic caspase dependent apoptosis induction and metastasis obstruction.
Piryaei M; Mehrparvar B; Mohammadian A; Shahriari F; Javidi MA
Eur J Pharmacol; 2021 Nov; 910():174454. PubMed ID: 34454929
[TBL] [Abstract] [Full Text] [Related]
5. Highly accurate diagnosis of papillary thyroid carcinomas based on personalized pathways coupled with machine learning.
Park KS; Kim SH; Oh JH; Kim SY
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33341874
[TBL] [Abstract] [Full Text] [Related]
6. Can galectin-3 be a useful marker for conventional papillary thyroid microcarcinoma?
Gweon HM; Kim JA; Youk JH; Hong SW; Lim BJ; Yoon SO; Park YM; Son EJ
Diagn Cytopathol; 2016 Feb; 44(2):103-7. PubMed ID: 26681546
[TBL] [Abstract] [Full Text] [Related]
7. Risk factors for the development of uterine cancer in breast cancer survivors: an army of women study.
Torres D; Myers JA; Eshraghi LW; Riley EC; Soliman PT; Milam MR
Ann Surg Oncol; 2015; 22(6):1974-9. PubMed ID: 25361886
[TBL] [Abstract] [Full Text] [Related]
8. Carbonic anhydrase 4 and crystallin α-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology.
Davidov T; Nagar M; Kierson M; Chekmareva M; Chen C; Lu SE; Lin Y; Chernyavsky V; Potdevin L; Arumugam D; Barnard N; Trooskin S
J Surg Res; 2014 Aug; 190(2):565-74. PubMed ID: 24880201
[TBL] [Abstract] [Full Text] [Related]
9. Immunohistochemical expression of HBME-1, E-cadherin, and CD56 in the differential diagnosis of thyroid nodules.
Ozolins A; Narbuts Z; Strumfa I; Volanska G; Stepanovs K; Gardovskis J
Medicina (Kaunas); 2012; 48(10):507-14. PubMed ID: 23324246
[TBL] [Abstract] [Full Text] [Related]
10. A molecular computational model improves the preoperative diagnosis of thyroid nodules.
Tomei S; Marchetti I; Zavaglia K; Lessi F; Apollo A; Aretini P; Di Coscio G; Bevilacqua G; Mazzanti C
BMC Cancer; 2012 Sep; 12():396. PubMed ID: 22958914
[TBL] [Abstract] [Full Text] [Related]
11. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review.
Soelberg KK; Bonnema SJ; Brix TH; Hegedüs L
Thyroid; 2012 Sep; 22(9):918-25. PubMed ID: 22827552
[TBL] [Abstract] [Full Text] [Related]
12. Methylation status of genes in papillary thyroid carcinoma.
Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
[TBL] [Abstract] [Full Text] [Related]
13. [The use of immunohistochemistry in the differential diagnosis of thyroid gland tumors with follicular growth pattern].
Laco J; Ryska A
Cesk Patol; 2006 Jul; 42(3):120-4. PubMed ID: 16955558
[TBL] [Abstract] [Full Text] [Related]
14. [Progress of clinical pathology and application of PET-CT on thyroid carcinoma].
Gao M; Li XL; Yu Y; Sun BC; Li SL; Xu WG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jun; 41(6):419-24. PubMed ID: 16927796
[TBL] [Abstract] [Full Text] [Related]
15. Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer.
Hu S; Ewertz M; Tufano RP; Brait M; Carvalho AL; Liu D; Tufaro AP; Basaria S; Cooper DS; Sidransky D; Ladenson PW; Xing M
J Clin Endocrinol Metab; 2006 Jan; 91(1):98-104. PubMed ID: 16263813
[TBL] [Abstract] [Full Text] [Related]
16. Quantitative assessment of promoter methylation profiles in thyroid neoplasms.
Hoque MO; Rosenbaum E; Westra WH; Xing M; Ladenson P; Zeiger MA; Sidransky D; Umbricht CB
J Clin Endocrinol Metab; 2005 Jul; 90(7):4011-8. PubMed ID: 15840741
[TBL] [Abstract] [Full Text] [Related]
